Wealth Enhancement Advisory Services LLC Invests $719,000 in GRAIL, Inc. (NASDAQ:GRAL)

Wealth Enhancement Advisory Services LLC bought a new position in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 28,163 shares of the company's stock, valued at approximately $719,000. Wealth Enhancement Advisory Services LLC owned approximately 0.08% of GRAIL as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Lindbrook Capital LLC acquired a new position in shares of GRAIL during the 4th quarter worth $28,000. State of Tennessee Department of Treasury acquired a new position in shares of GRAIL during the 4th quarter worth $28,000. Caldwell Sutter Capital Inc. acquired a new position in shares of GRAIL during the 1st quarter worth $28,000. Sterling Capital Management LLC acquired a new position in shares of GRAIL during the 4th quarter worth $29,000. Finally, Wellington Shields Capital Management LLC acquired a new position in shares of GRAIL during the 4th quarter worth $33,000.

Insider Transactions at GRAIL

In other news, President Joshua J. Ofman sold 9,692 shares of the business's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $52.00, for a total transaction of $503,984.00. Following the completion of the sale, the president owned 492,076 shares in the company, valued at approximately $25,587,952. The trade was a 1.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Chun R. Ding sold 339,800 shares of the business's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total value of $16,830,294.00. Following the sale, the insider owned 3,305,055 shares of the company's stock, valued at $163,699,374.15. The trade was a 9.32% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 532,890 shares of company stock worth $23,556,972 over the last 90 days.

Wall Street Analyst Weigh In

GRAL has been the subject of several research reports. Canaccord Genuity Group lifted their price target on GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Morgan Stanley boosted their target price on shares of GRAIL from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th.

GRAIL Trading Down 4.0%

GRAL traded down $1.87 during midday trading on Monday, hitting $44.85. The company's stock had a trading volume of 1,247,497 shares, compared to its average volume of 1,188,435. The firm has a market cap of $1.61 billion and a P/E ratio of -0.74. The firm has a 50-day moving average price of $40.95 and a two-hundred day moving average price of $33.11. GRAIL, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. The business had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. On average, equities analysts expect that GRAIL, Inc. will post -15.15 EPS for the current year.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.